Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1951 1
1962 1
1973 1
1977 3
1978 2
1979 4
1980 4
1981 2
1982 8
1983 2
1984 5
1985 10
1986 3
1987 5
1988 3
1989 6
1990 5
1991 8
1992 4
1993 8
1994 5
1995 4
1996 5
1997 4
1998 7
1999 3
2000 7
2001 3
2002 8
2003 11
2004 5
2005 6
2006 12
2007 11
2008 13
2009 11
2010 8
2011 9
2012 8
2013 7
2014 4
2015 6
2016 6
2017 8
2018 5
2019 4
2020 1
2021 6
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

264 results
Results by year
Filters applied: . Clear all
Page 1
Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma.
Johnson EF, Davis DM, Tollefson MM, Fritchie K, Gibson LE. Johnson EF, et al. Am J Dermatopathol. 2018 Apr;40(4):231-239. doi: 10.1097/DAD.0000000000000983. Am J Dermatopathol. 2018. PMID: 29561329 Review.
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.
Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, Jin S, Johnson EF, Marsh KC, Mitten MJ, Nimmer P, Roberts L, Tahir SK, Xiao Y, Yang X, Zhang H, Fesik S, Rosenberg SH, Elmore SW. Tse C, et al. Among authors: johnson ef. Cancer Res. 2008 May 1;68(9):3421-8. doi: 10.1158/0008-5472.CAN-07-5836. Cancer Res. 2008. PMID: 18451170
Navigating the kinome.
Metz JT, Johnson EF, Soni NB, Merta PJ, Kifle L, Hajduk PJ. Metz JT, et al. Among authors: johnson ef. Nat Chem Biol. 2011 Apr;7(4):200-2. doi: 10.1038/nchembio.530. Epub 2011 Feb 20. Nat Chem Biol. 2011. PMID: 21336281
Investigation of biaryl heterocycles as inhibitors of Wee1 kinase.
Mastracchio A, Lai C, Torrent M, Bromberg K, Buchanan FG, Ferguson D, Bontcheva V, Johnson EF, Lasko L, Maag D, Shoemaker AR, Penning TD. Mastracchio A, et al. Among authors: johnson ef. Bioorg Med Chem Lett. 2019 Jun 15;29(12):1481-1486. doi: 10.1016/j.bmcl.2019.04.017. Epub 2019 Apr 9. Bioorg Med Chem Lett. 2019. PMID: 31014911
Heterologous expression of human drug-metabolizing enzymes.
Guengerich FP, Parikh A, Johnson EF, Richardson TH, von Wachenfeldt C, Cosme J, Jung F, Strassburg CP, Manns MP, Tukey RH, Pritchard M, Fournel-Gigleux S, Burchell B. Guengerich FP, et al. Among authors: johnson ef. Drug Metab Dispos. 1997 Nov;25(11):1234-41. Drug Metab Dispos. 1997. PMID: 9351898 Review.
Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer.
Kozono DE, Stinchcombe TE, Salama JK, Bogart J, Petty WJ, Guarino MJ, Bazhenova L, Larner JM, Weiss J, DiPetrillo TA, Feigenberg SJ, Chen X, Sun Z, Nuthalapati S, Rosenwinkel L, Johnson EF, Bach BA, Luo Y, Vokes EE. Kozono DE, et al. Among authors: johnson ef. Lung Cancer. 2021 Sep;159:56-65. doi: 10.1016/j.lungcan.2021.06.028. Epub 2021 Jul 21. Lung Cancer. 2021. PMID: 34311345 Free article.
264 results